물리치료 장비 시장 : 제품별(장비(전기 요법, 초음파 요법, 냉동 요법, 레이저 요법), 액세서리), 용도별(근골격 및 정형외과, 신경계, 스포츠 재활), 최종사용자별, 지역별 - 세계 예측(-2031년)

The global physiotherapy equipment market size is projected to reach USD 8.37 billion by 2031 from USD 6.11 billion in 2026, at a CAGR of 6.5% during the forecast period.

Lifestyle factors, such as lack of exercise and poor dieting, compounded by an aging population, explain the growth of chronic illnesses like arthritis and cardiovascular diseases. The rehabilitation requirements increase correspondingly. Concomitantly, the increased number of rehabilitation requirements leads to an upsurge in demand for physiotherapy equipment for managing older people's mobility and pain relief. The market is also driven by several other factors, such as technological advancements, rising R&D spending, increased awareness, the need for personalized physiotherapy equipment, and economic expansion in emerging countries.

"The electrotherapy segment is expected to dominate the market."

Electrotherapy is one of the most widely adopted modalities in physiotherapy for pain management, muscle rehabilitation, and functional recovery across musculoskeletal and neurological conditions. Common electrotherapy techniques include Transcutaneous Electrical Nerve Stimulation (TENS), Interferential Therapy (IFT), Electrical Muscle Stimulation (EMS), Percutaneous Electrical Nerve Stimulation (PENS), and Therapeutic Ultrasound. These modalities provide non-invasive treatment options that help relieve acute and chronic pain, accelerate the healing of musculoskeletal injuries, improve blood circulation, promote wound healing, reduce inflammation, and relax muscle spasms, with minimal side effects. Technological advancements have further enhanced treatment efficacy through the development of compact, portable, and digitally connected electrotherapy devices, enabling both clinical and home-based rehabilitation. Furthermore, the growing availability of programmable treatment protocols and personalized therapy settings has improved patient adherence, convenience, and overall rehabilitation outcomes, supporting the increasing adoption of electrotherapy equipment across healthcare settings.

"Musculoskeletal & orthopedic rehabilitation segment accounted for the largest share of the applications market in 2025."

Musculoskeletal and orthopedic rehabilitation plays a vital role in the treatment and recovery of conditions such as ligament sprains, muscle strains, osteoarthritis, fractures, spinal disorders, cartilage injuries, joint replacements, and other pre- and post-operative orthopedic conditions. The increasing burden of musculoskeletal and orthopedic disorders is driven by a rapidly aging population, rising participation in sports and recreational activities, sedentary lifestyles, increasing obesity rates, and repetitive occupational strain. Furthermore, the growing incidence of road traffic accidents, workplace injuries, and trauma-related musculoskeletal conditions has accelerated the demand for rehabilitation services. As healthcare providers increasingly emphasize early intervention, functional recovery, and improved mobility, the adoption of advanced physiotherapy equipment across hospitals, rehabilitation centers, outpatient clinics, and home care settings continues to expand, supporting enhanced clinical outcomes and reducing long-term disability.

"The Asia Pacific is estimated to register the highest CAGR during the forecast period."

The physiotherapy equipment market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. The Asia Pacific is projected to register the highest CAGR during the forecast period. The region's growth is primarily driven by its rapidly aging population, increasing incidence of musculoskeletal disorders, stroke, and sports injuries, and rising awareness regarding early rehabilitation and physiotherapy. In addition, expanding healthcare infrastructure, increasing healthcare expenditure, improving access to rehabilitation services, and favorable government initiatives in countries such as China, India, Japan, South Korea, and Australia are accelerating the adoption of advanced physiotherapy equipment. The growing number of rehabilitation centers, coupled with increasing investments by both public and private healthcare providers, is expected to further drive market growth across the region.

The break-up of the profile of primary participants in the physiotherapy equipment market:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: C-level - 27%, D-level - 18%, and Others - 55%
• By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa- 4%

The prominent players operating in the physiotherapy equipment market are Enovis Corp. (US), BTL Industries (UK), Performance Health (US), ITO Co., Ltd. (Japan), Enraf-Nonius B.V. (Netherlands), Dynatronics Corporation (US), Mectronic Medicale (Italy), Zimmer MedizinSysteme GmbH (Germany), Altivera Medical, Inc. (formerly Zynex Inc.) (US), Tactile Medical (US), Technogym SpA (Italy), Richmar (US), Storz Medical AG (Germany), DIH Medical (Switzerland), OG Wellness Technologies Co., Ltd. (Japan), Gymna (Belgium), Omron Corporation (Japan), Physiomed Elektromedizin AG (Germany), Guangzhou Longest Science&Technology Co., Ltd. (China), Astar (Poland), KINVENT (France), ExoAtlet (Luxembourg), ManaMed (US), BeAble Health Pvt. Ltd. (India), and Balance Metrix (Australia).

Research Coverage

This report examines the physiotherapy equipment market by product, application, end-user, and region. The report also analyses factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the market opportunities and challenges for stakeholders and provides details on the competitive landscape for market leaders. The report also examines micro-markets in terms of their growth trends, prospects, and contributions to the total physiotherapy equipment market. The report forecasts revenue for the market segments across five major regions.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall physiotherapy equipment market and the subsegments. This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (rapid aging, technological advancements), restraints (unstable reimbursement scenario), challenges (alternate therapies), and opportunities (rise in home healthcare services)
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, in the physiotherapy equipment Market.
• Market Development: Comprehensive information on the lucrative emerging markets by products, applications, end users, and region.
• Market Diversification: Exhaustive information about the growing geographies, recent developments, and investments in the physiotherapy equipment market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global physiotherapy equipment market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH
• 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
• 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 OPPORTUNITIES FOR PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET
• 3.2 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER AND COUNTRY (2025)
• 3.3 PHYSIOTHERAPY EQUIPMENT MARKET: KEY COUNTRIES
• 3.4 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION (2026-2031)
• 3.5 PHYSIOTHERAPY EQUIPMENT MARKET: DEVELOPED VS. EMERGING MARKETS

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Rapidly growing geriatric population and increasing incidence of chronic diseases
    • 4.2.1.2 Growing incidence of sports injuries, degenerative joint disorders, and cerebrovascular diseases
    • 4.2.1.3 Rising demand for rehabilitation care
    • 4.2.1.4 Growing demand for home-based and telerehabilitation care
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 Unstable reimbursement scenario for physiotherapy
    • 4.2.2.2 Direct access to physiotherapy
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Emerging markets
    • 4.2.3.2 Rising technological advancements
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Shortage of skilled personnel
    • 4.2.4.2 Alternate therapies such as acupuncture
• 4.3 UNMET NEEDS & WHITE SPACES
  • 4.3.1 UNMET NEEDS IN PHYSIOTHERAPY EQUIPMENT MARKET
  • 4.3.2 WHITE SPACE OPPORTUNITIES
• 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
  • 4.4.1 INTERCONNECTED MARKETS
  • 4.4.2 CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 THREAT OF SUBSTITUTES
  • 5.1.3 BARGAINING POWER OF SUPPLIERS
  • 5.1.4 BARGAINING POWER OF BUYERS
  • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.2 MACROECONOMIC OUTLOOK
  • 5.2.1 INTRODUCTION
  • 5.2.2 GDP TRENDS & FORECAST
  • 5.2.3 TRENDS IN REHABILITATION EQUIPMENT INDUSTRY
• 5.3 SUPPLY CHAIN ANALYSIS
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 ECOSYSTEM ANALYSIS
  • 5.5.1 ROLE IN ECOSYSTEM
• 5.6 PRICING ANALYSIS
  • 5.6.1 AVERAGE SELLING PRICE OF PHYSIOTHERAPY EQUIPMENT, BY PRODUCT, 2025
  • 5.6.2 AVERAGE SELLING PRICE OF PHYSIOTHERAPY EQUIPMENT, BY REGION, 2023-2025
• 5.7 TRADE ANALYSIS
  • 5.7.1 IMPORT DATA FOR PHYSIOTHERAPY EQUIPMENT (HS CODE: 9019), 2021-2025
  • 5.7.2 EXPORT DATA FOR PHYSIOTHERAPY EQUIPMENT (HS CODE: 9019), 2021-2025
• 5.8 KEY CONFERENCES & EVENTS, 2026-2027
• 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.10 CASE STUDY ANALYSIS
  • 5.10.1 CASE STUDY 1: STARTOON LABS RECEIVED USFDA APPROVAL FOR PHEEZEE PHYSIOTHERAPY DEVICE
  • 5.10.2 CASE STUDY 2: NHS IN THE UK TO LAUNCH AI-DRIVEN PHYSIOTHERAPY CLINIC
  • 5.10.3 CASE STUDY 3: BURJEEL AND LEEJAM LAUNCH PHYSIOTHERABIA CENTERS IN RIYADH
• 5.11 INVESTMENT & FUNDING SCENARIO
• 5.12 IMPACT OF 2025 US TARIFFS ON PHYSIOTHERAPY EQUIPMENT MARKET
  • 5.12.1 INTRODUCTION
  • 5.12.2 KEY TARIFF RATES
  • 5.12.3 PRICE IMPACT ANALYSIS
  • 5.12.4 IMPACT ON REGION
    • 5.12.4.1 US
    • 5.12.4.2 Europe
    • 5.12.4.3 Asia Pacific
  • 5.12.5 IMPACT ON END-USE INDUSTRIES

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS

• 6.1 KEY EMERGING TECHNOLOGIES
• 6.2 COMPLEMENTARY TECHNOLOGIES
  • 6.2.1 AUGMENTED REALITY (AR)
• 6.3 TECHNOLOGY/PRODUCT ROADMAP
  • 6.3.1 SHORT-TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
  • 6.3.2 MID-TERM (2027-2030) | EXPANSION & STANDARDIZATION
  • 6.3.3 LONG-TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
• 6.4 PATENT ANALYSIS
  • 6.4.1 PATENT PUBLICATION TRENDS FOR PHYSIOTHERAPY EQUIPMENT MARKET
  • 6.4.2 TOP APPLICANTS (COMPANIES) OF PHYSIOTHERAPY EQUIPMENT PATENTS
  • 6.4.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN PHYSIOTHERAPY EQUIPMENT MARKET
  • 6.4.4 LIST OF MAJOR PATENTS
• 6.5 IMPACT OF AI/GEN AI ON PHYSIOTHERAPY EQUIPMENT MARKET
  • 6.5.1 TOP USE CASES & MARKET POTENTIAL
  • 6.5.2 TOP CASE STUDIES OF AI IMPLEMENTATION IN PHYSIOTHERAPY EQUIPMENT MARKET
  • 6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
  • 6.5.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN PHYSIOTHERAPY EQUIPMENT MARKET
• 6.6 SUCCESS STORIES & REAL-WORLD APPLICATIONS
  • 6.6.1 DIH MEDICAL/HOCOMA: LOKOMAT (ROBOT-ASSISTED GAIT REHABILITATION)
  • 6.6.2 BTL INDUSTRIES: EMSELLA (NON-INVASIVE PELVIC FLOOR REHABILITATION)
  • 6.6.3 STORZ MEDICAL: DUOLITH SD1 "ULTRA"(COMBINED SHOCKWAVE THERAPY IN SPORTS REHABILITATION)

7 SUSTAINABILITY & REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS & COMPLIANCE
  • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 7.1.2 INDUSTRY STANDARDS
    • 7.1.2.1 North America
      • 7.1.2.1.1 US
      • 7.1.2.1.2 Canada
    • 7.1.2.2 Europe
    • 7.1.2.3 Asia Pacific
      • 7.1.2.3.1 Japan
      • 7.1.2.3.2 China
      • 7.1.2.3.3 India
• 7.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
  • 7.2.1 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN PHYSIOTHERAPY EQUIPMENT

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 8.1 DECISION-MAKING PROCESS
• 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
  • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.2.2 KEY BUYING CRITERIA
• 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 8.4 UNMET NEEDS IN END USERS
• 8.5 MARKET PROFITABILITY
  • 8.5.1 REVENUE POTENTIAL
  • 8.5.2 COST DYNAMICS
  • 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

9 PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT

• 9.1 INTRODUCTION
• 9.2 EQUIPMENT
  • 9.2.1 ELECTROTHERAPY EQUIPMENT
    • 9.2.1.1 Rising demand for non-pharmacological pain-management options to drive market growth
  • 9.2.2 ULTRASOUND EQUIPMENT
    • 9.2.2.1 High prevalence of musculoskeletal disorders and sports injuries and growing postoperative rehabilitation needs to boost growth
  • 9.2.3 EXERCISE THERAPY EQUIPMENT
    • 9.2.3.1 Shift toward active, function-oriented rehabilitation and growing emphasis on measurable clinical outcomes to fuel market growth
  • 9.2.4 HEAT THERAPY EQUIPMENT
    • 9.2.4.1 Expansion of outpatient rehabilitation and availability of portable products for supervised home use to drive growth
  • 9.2.5 CRYOTHERAPY EQUIPMENT
    • 9.2.5.1 Increasing orthopedic procedure volumes to support market growth
  • 9.2.6 COMBINATION THERAPY EQUIPMENT
    • 9.2.6.1 Ability of combination systems to consolidate capital purchases and improve clinical workflow to drive demand
  • 9.2.7 CONTINUOUS PASSIVE MOTION THERAPY EQUIPMENT
    • 9.2.7.1 Ability to maintain passive joint mobility and reduce adverse effects of prolonged immobilization to fuel market
  • 9.2.8 SHOCKWAVE THERAPY EQUIPMENT
    • 9.2.8.1 Availability of compact radial systems suitable for physiotherapy and sports medicine clinics to boost demand
  • 9.2.9 LASER THERAPY EQUIPMENT
    • 9.2.9.1 Ability of higher-power systems to treat larger areas within shorter sessions to fuel growth
  • 9.2.10 TRACTION THERAPY EQUIPMENT
    • 9.2.10.1 Availability of programmable clinic-based and portable home-use devices to support growth
  • 9.2.11 MAGNETIC PRESSURE THERAPY EQUIPMENT
    • 9.2.11.1 Introduction of higher-intensity systems capable of stimulating deeper tissues without direct skin contact to drive adoption
  • 9.2.12 OTHER PHYSIOTHERAPY EQUIPMENT
• 9.3 ACCESSORIES
  • 9.3.1 PHYSIOTHERAPY FURNITURE
    • 9.3.1.1 Growing use for physical therapy, rehab, occupational therapy, sports medicine, and chiropractic medicine to drive market
  • 9.3.2 OTHER ACCESSORIES

10 PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION

• 10.1 INTRODUCTION
• 10.2 MUSCULOSKELETAL & ORTHOPEDIC REHABILITATION
  • 10.2.1 RISING INCIDENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE DEMAND
• 10.3 NEUROLOGICAL REHABILITATION
  • 10.3.1 SIGNIFICANT UNMET REHABILITATION NEEDS, PARTICULARLY IN EMERGING ECONOMIES, TO CREATE LONG-TERM MARKET OPPORTUNITY
• 10.4 CARDIOVASCULAR & PULMONARY REHABILITATION
  • 10.4.1 GROWING CARDIOVASCULAR AND RESPIRATORY DISEASE BURDEN TO DRIVE DEMAND FOR EXERCISE THERAPY EQUIPMENT
• 10.5 SPORTS REHABILITATION
  • 10.5.1 DEMAND FOR STRUCTURED REHABILITATION AND OBJECTIVE RETURN-TO-PLAY ASSESSMENTS TO BOOST MARKET
• 10.6 PELVIC HEALTH & UROGYNECOLOGICAL REHABILITATION
  • 10.6.1 SHIFT TOWARD OUTPATIENT, HOME-BASED, AND REMOTELY MONITORED PELVIC-HEALTH PROGRAMS TO EXPAND ADDRESSABLE EQUIPMENT BASE
• 10.7 OTHER APPLICATIONS

11 PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER

• 11.1 INTRODUCTION
• 11.2 PHYSIOTHERAPY & REHABILITATION CENTERS
  • 11.2.1 RISING INCIDENCE OF SPORTS INJURIES AND DISABILITIES TO DRIVE SEGMENT
• 11.3 HOSPITALS
  • 11.3.1 GROWING PATIENT VOLUMES AT HOSPITALS TO DRIVE DEMAND
• 11.4 HOME CARE SETTINGS
  • 11.4.1 RISING DEMAND FOR HOME CARE TO DRIVE DEMAND
• 11.5 PHYSICIANS' OFFICES
  • 11.5.1 COST-SAVING POTENTIAL AND QUALITY OF CARE PROVIDED IN PHYSICIANS' OFFICES TO DRIVE GROWTH
• 11.6 OTHER END USERS

12 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 12.2.2 US
    • 12.2.2.1 US to dominate North American market during forecast period
  • 12.2.3 CANADA
    • 12.2.3.1 Growing penetration of preventive care services to boost market
• 12.3 EUROPE
  • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 12.3.2 GERMANY
    • 12.3.2.1 Rising geriatric population and increase in chronic conditions to drive demand
  • 12.3.3 UK
    • 12.3.3.1 Wide acceptance of physical therapy to increase adoption of physiotherapy equipment
  • 12.3.4 FRANCE
    • 12.3.4.1 Rising healthcare expenditure and favorable reimbursement scenario to drive market
  • 12.3.5 ITALY
    • 12.3.5.1 Increasing incidence of fall injuries and orthopedic disorders to drive market
  • 12.3.6 SPAIN
    • 12.3.6.1 Rising geriatric population to drive adoption of physiotherapy equipment
  • 12.3.7 REST OF EUROPE
• 12.4 ASIA PACIFIC
  • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 12.4.2 JAPAN
    • 12.4.2.1 Large geriatric population to drive adoption of physiotherapy equipment
  • 12.4.3 CHINA
    • 12.4.3.1 Global manufacturing hub for physiotherapy and rehabilitation equipment to drive market
  • 12.4.4 INDIA
    • 12.4.4.1 Expansion of new acute care settings to drive demand
  • 12.4.5 AUSTRALIA
    • 12.4.5.1 Growing population and rising cases of chronic musculoskeletal conditions to drive market
  • 12.4.6 SOUTH KOREA
    • 12.4.6.1 Fast-growing aging population and rising medical tourism to drive market
  • 12.4.7 REST OF ASIA PACIFIC
• 12.5 LATIN AMERICA
  • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 12.5.2 BRAZIL
    • 12.5.2.1 Rapidly aging population and expanding healthcare infrastructure to augment market growth
  • 12.5.3 MEXICO
    • 12.5.3.1 Advancements in healthcare infrastructure to drive market
  • 12.5.4 ARGENTINA
    • 12.5.4.1 Advancements in healthcare infrastructure to drive market
  • 12.5.5 REST OF LATIN AMERICA
• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 12.6.2 GCC COUNTRIES
    • 12.6.2.1 Robust healthcare industry to drive market
  • 12.6.3 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

• 13.1 OVERVIEW
• 13.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
  • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET
• 13.3 REVENUE ANALYSIS, 2021-2025
• 13.4 MARKET RANKING ANALYSIS
• 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
  • 13.5.1 STARS
  • 13.5.2 EMERGING LEADERS
  • 13.5.3 PERVASIVE PLAYERS
  • 13.5.4 PARTICIPANTS
  • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 13.5.5.1 Company footprint
    • 13.5.5.2 Region footprint
    • 13.5.5.3 Product footprint
    • 13.5.5.4 Application footprint
    • 13.5.5.5 End-user footprint
• 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 13.6.1 PROGRESSIVE COMPANIES
  • 13.6.2 RESPONSIVE COMPANIES
  • 13.6.3 DYNAMIC COMPANIES
  • 13.6.4 STARTING BLOCKS
  • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
    • 13.6.5.1 List of key startups/SMEs
    • 13.6.5.2 Competitive benchmarking of key startups/SMEs
• 13.7 BRAND/PRODUCT COMPARISON
• 13.8 COMPANY VALUATION & FINANCIAL METRICS
  • 13.8.1 FINANCIAL METRICS
  • 13.8.2 COMPANY VALUATION
• 13.9 COMPETITIVE SCENARIO
  • 13.9.1 PRODUCT LAUNCHES & APPROVALS
  • 13.9.2 DEALS
  • 13.9.3 EXPANSIONS
  • 13.9.4 OTHER DEVELOPMENTS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
  • 14.1.1 ENOVIS CORPORATION (FORMERLY COLFAX CORPORATION)
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products offered
    • 14.1.1.3 Recent developments
      • 14.1.1.3.1 Product launches
      • 14.1.1.3.2 Deals
      • 14.1.1.3.3 Expansions
      • 14.1.1.3.4 Other developments
    • 14.1.1.4 MnM view
      • 14.1.1.4.1 Right to win
      • 14.1.1.4.2 Strategic choices
      • 14.1.1.4.3 Weaknesses & competitive threats
  • 14.1.2 ZIMMER MEDIZINSYSTEME GMBH
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products offered
    • 14.1.2.3 Recent developments
      • 14.1.2.3.1 Product launches
      • 14.1.2.3.2 Deals
      • 14.1.2.3.3 Other developments
    • 14.1.2.4 MnM view
      • 14.1.2.4.1 Right to win
      • 14.1.2.4.2 Strategic choices
      • 14.1.2.4.3 Weaknesses & competitive threats
  • 14.1.3 ALTIVERA MEDICAL, INC. (FORMERLY ZYNEX, INC.)
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products offered
    • 14.1.3.3 Recent developments
      • 14.1.3.3.1 Product launches & approvals
      • 14.1.3.3.2 Deals
      • 14.1.3.3.3 Expansions
      • 14.1.3.3.4 Other developments
    • 14.1.3.4 MnM view
      • 14.1.3.4.1 Right to win
      • 14.1.3.4.2 Strategic choices
      • 14.1.3.4.3 Weaknesses & competitive threats
  • 14.1.4 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS)
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products offered
    • 14.1.4.3 Recent developments
      • 14.1.4.3.1 Product launches
      • 14.1.4.3.2 Deals
      • 14.1.4.3.3 Other developments
    • 14.1.4.4 MnM view
      • 14.1.4.4.1 Right to win
      • 14.1.4.4.2 Strategic choices
      • 14.1.4.4.3 Weaknesses & competitive threats
  • 14.1.5 ITO CO., LTD.
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products offered
    • 14.1.5.3 MnM view
      • 14.1.5.3.1 Right to win
      • 14.1.5.3.2 Strategic choices
      • 14.1.5.3.3 Weaknesses & competitive threats
  • 14.1.6 DYNATRONICS CORPORATION
    • 14.1.6.1 Business overview
    • 14.1.6.2 Products offered
    • 14.1.6.3 Recent developments
      • 14.1.6.3.1 Product launches
      • 14.1.6.3.2 Deals
      • 14.1.6.3.3 Other developments
  • 14.1.7 BTL INDUSTRIES
    • 14.1.7.1 Business overview
    • 14.1.7.2 Products offered
    • 14.1.7.3 Recent developments
      • 14.1.7.3.1 Product launches
      • 14.1.7.3.2 Deals
      • 14.1.7.3.3 Expansions
      • 14.1.7.3.4 Other developments
  • 14.1.8 ENRAF-NONIUS B.V.
    • 14.1.8.1 Business overview
    • 14.1.8.2 Products offered
    • 14.1.8.3 Recent developments
      • 14.1.8.3.1 Deals
  • 14.1.9 MECTRONIC MEDICALE
    • 14.1.9.1 Business overview
    • 14.1.9.2 Products offered
  • 14.1.10 RICHMAR (SUBSIDIARY OF DRIVE MEDICAL)
    • 14.1.10.1 Business overview
    • 14.1.10.2 Products offered
    • 14.1.10.3 Recent developments
      • 14.1.10.3.1 Product launches
      • 14.1.10.3.2 Deals
  • 14.1.11 STORZ MEDICAL AG
    • 14.1.11.1 Business overview
    • 14.1.11.2 Products offered
    • 14.1.11.3 Recent developments
      • 14.1.11.3.1 Product launches
      • 14.1.11.3.2 Deals
      • 14.1.11.3.3 Expansions
  • 14.1.12 GYMNA INTERNATIONAL
    • 14.1.12.1 Business overview
    • 14.1.12.2 Products offered
    • 14.1.12.3 Recent developments
      • 14.1.12.3.1 Product launches
  • 14.1.13 ASTAR
    • 14.1.13.1 Business overview
    • 14.1.13.2 Products offered
  • 14.1.14 PHYSIOMED ELEKTROMEDIZIN AG (FORMERLY PROXOMED)
    • 14.1.14.1 Business overview
    • 14.1.14.2 Products offered
  • 14.1.15 TACTILE MEDICAL
    • 14.1.15.1 Business overview
    • 14.1.15.2 Products offered
    • 14.1.15.3 Recent developments
      • 14.1.15.3.1 Product launches
  • 14.1.16 DIH MEDICAL
    • 14.1.16.1 Business overview
    • 14.1.16.2 Products offered
    • 14.1.16.3 Recent developments
      • 14.1.16.3.1 Product launches
      • 14.1.16.3.2 Deals
      • 14.1.16.3.3 Other developments
  • 14.1.17 TECHNOGYM SPA
    • 14.1.17.1 Business overview
    • 14.1.17.2 Products offered
    • 14.1.17.3 Recent developments
      • 14.1.17.3.1 Expansions
  • 14.1.18 OMRON CORPORATION
    • 14.1.18.1 Business overview
    • 14.1.18.2 Products offered
  • 14.1.19 OG WELLNESS TECHNOLOGIES CO., LTD.
    • 14.1.19.1 Business overview
    • 14.1.19.2 Products offered
    • 14.1.19.3 Recent developments
      • 14.1.19.3.1 Deals
  • 14.1.20 GUANGZHOU LONGEST MEDICAL TECHNOLOGY CO., LTD.
    • 14.1.20.1 Business overview
    • 14.1.20.2 Products offered
    • 14.1.20.3 Recent developments
      • 14.1.20.3.1 Product approvals & launches
• 14.2 OTHER PLAYERS
  • 14.2.1 KINVENT
  • 14.2.2 EXOATLET
  • 14.2.3 MANAMED
  • 14.2.4 BEABLE HEALTH PVT. LTD.
  • 14.2.5 BALANCE METRIX

15 RESEARCH METHODOLOGY

• 15.1 RESEARCH APPROACH
  • 15.1.1 SECONDARY DATA
    • 15.1.1.1 Key data from secondary sources
  • 15.1.2 PRIMARY DATA
    • 15.1.2.1 Key data from primary sources
    • 15.1.2.2 Key industry insights
• 15.2 MARKET SIZE ESTIMATION
  • 15.2.1 BOTTOM-UP APPROACH
  • 15.2.2 TOP-DOWN APPROACH
  • 15.2.3 BASE NUMBER ESTIMATION
• 15.3 MARKET FORECAST APPROACH
• 15.4 MARKET BREAKDOWN & DATA TRIANGULATION
• 15.5 RESEARCH ASSUMPTIONS
• 15.6 FACTOR ANALYSIS
• 15.7 RESEARCH LIMITATIONS
  • 15.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 15.7.2 SCOPE-RELATED LIMITATIONS
• 15.8 RISK ASSESSMENT

16 APPENDIX

• 16.1 DISCUSSION GUIDE
• 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 16.3 CUSTOMIZATION OPTIONS
• 16.4 RELATED REPORTS
• 16.5 AUTHOR DETAILS